Cowl v. United States

124 F. 475, 1900 U.S. App. LEXIS 4957
CourtU.S. Circuit Court for the District of Southern New York
DecidedJuly 2, 1900
DocketNo. 3,007
StatusPublished
Cited by5 cases

This text of 124 F. 475 (Cowl v. United States) is published on Counsel Stack Legal Research, covering U.S. Circuit Court for the District of Southern New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cowl v. United States, 124 F. 475, 1900 U.S. App. LEXIS 4957 (circtsdny 1900).

Opinion

LACOMBE, Circuit Judge

(after stating the facts). The-testimony in this case was all taken in the Circuit Court, none having been introduced before the board, and the government raises the objection that it cannot, therefore, be considered here under the decision of the Circuit Court of Appeals' in U. S. v. China & Japan Trading Company, 18 C. C. A. 335, 71 Fed. 864.

The two cases, however, are not alike. In U. S. v. China & Japan Trading Company it appeared from the record that the board affirmed the collector because the importer failed to appear pursuant to- its notification to show cause why the collector should not be affirmed. In the case at bar, however, the return states:

“This case was continued and held open for the importer to produce testimony, which their attorneys stated they desired to offer in regard to the crudity of the merchandise and its mode of treatment before it could be used as a medicinal preparation; but, it appearing from the facts stated herein that such testimony would not be material, the case was decided on that ground, without waiting for the production of such evidence.”

It would seem, therefore, that it was not the importer’s fault that the evidence now in the cause was not presented to the board, and the reasoning in the China & Japan Trading Company Case does not apply.

The testimony brings the case clearly within the decision of the Circuit Court of Appeals in this circuit as to elaterium. U. S. v. Merck, 13 C. C. A. 432, 66 Fed. 251. The article is a crude drug, and not a medicinal preparation.

Decision of the board and of the collector reversed.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

B. L. Lemke & Co. v. United States
39 Cust. Ct. 253 (U.S. Customs Court, 1957)
George Beurhaus Co. v. United States
32 Cust. Ct. 269 (U.S. Customs Court, 1954)
United States v. Carr
11 Ct. Cust. 345 (Customs and Patent Appeals, 1922)
McKesson v. United States
3 Ct. Cust. 515 (Customs and Patent Appeals, 1913)
Strohmeyer & Arpe Co. v. United States
180 F. 636 (U.S. Circuit Court for the District of Southern New York, 1910)

Cite This Page — Counsel Stack

Bluebook (online)
124 F. 475, 1900 U.S. App. LEXIS 4957, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cowl-v-united-states-circtsdny-1900.